MedTrace Logo

Hydrolyzed Egg and Tolerance Induction

NCT01526863 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 29

Last updated 2015-01-16

No results posted yet for this study

Summary

The aim of this trial is to assess the effect of hydrolyzed egg orally administered on oral tolerance induction to egg in children allergic to egg as compared to a placebo.

Conditions

  • Allergy

Interventions

DIETARY_SUPPLEMENT

HA egg

Daily dose of HA egg or placebo for 6 months

Sponsors & Collaborators

  • Société des Produits Nestlé (SPN)

    lead INDUSTRY

Principal Investigators

  • Nikolaos Papadopoulos, Prof. · University of Athens, Greece

  • Antonella Muraro, Prof · University Hospital of Padua, Italy

  • Roger Lauener, Prof. · Hochgebirgsklinik Davos, Switzerland

  • Stavroula Giavi, Dr. · University of Athens, Greece

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
12 Months
Max Age
66 Months
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-10-31
Primary Completion
2014-07-31
Completion
2014-07-31

Countries

  • Greece
  • Italy
  • Switzerland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01526863 on ClinicalTrials.gov